MRK

Merck's stock price has experienced fluctuations in the past six months. As of early May 2026, MRK stock was down 5.85% over the past 30 days but up 41.94% over the past 12 months. The stock hit a 4-week low of $114.70 USD on April 21, 2026, and a 4-week high of $121.53 USD on March 30, 2026. Merck reported better-than-expected quarterly results on April 30, 2026, with Q1 2026 earnings per share (EPS) of -$1.28, beating analysts' estimates of -$1.47. Revenue for the quarter was $16.29 billion, surpassing expectations of $15.85 billion. The company also reaffirmed its full-year 2026 guidance for EPS between $5.04 and $5.16. Analyst ratings have generally been positive, with a consensus of "Moderate Buy" from 19 brokerages.